Glutamate—putrescine ligase
Glutamate—putrescine ligase is an enzyme that plays a crucial role in the biosynthesis of polyamines, a group of molecules essential for cell growth and differentiation. This enzyme catalyzes the ATP-dependent addition of a glutamate residue to putrescine, a key step in the production of spermidine, a polyamine involved in various cellular processes including DNA stabilization, transcription, translation, and cell proliferation.
Function[edit]
Glutamate—putrescine ligase (EC 6.3.1.11) is involved in the polyamine biosynthetic pathway, specifically in the conversion of putrescine to spermidine. Spermidine is vital for cellular functions and has roles in ribosome biogenesis, modulation of ion channels, and can act as a free radical scavenger. The activity of glutamate—putrescine ligase is critical for maintaining the cellular homeostasis of polyamines, which are necessary for cell growth and survival.
Structure[edit]
The structure of glutamate—putrescine ligase is not fully elucidated, but it is known to be a protein that requires ATP for its activity. The enzyme binds to its substrates, putrescine and glutamate, and catalyzes the formation of a bond between them using ATP, releasing AMP and a phosphate group in the process.
Clinical Significance[edit]
Alterations in the activity of glutamate—putrescine ligase have been implicated in various diseases, including cancer, where polyamine metabolism is often dysregulated. Inhibitors of this enzyme, therefore, have potential therapeutic applications in cancer treatment by limiting polyamine availability, which is necessary for rapid cell division.
Genetic Regulation[edit]
The gene encoding glutamate—putrescine ligase is regulated by various factors, including growth signals and environmental stresses, reflecting the need for tight control of polyamine levels within the cell. Understanding the regulation of this gene could provide insights into how polyamine metabolism is altered in diseases.
See Also[edit]
References[edit]
<references/>

This article is a biochemistry stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian